Legal Opinion
UCB, Inc. v. Yeda Research & Development Co.
Court of Appeals for the Federal Circuit
Decided September 8, 2016No. 2015-1957PublishedCited by 7 opinions
1Opinion of the Court
NEWMAN, Circuit Judge.
In this declaratory judgment action, UCB, Inc. sued Yeda Research and Development Co. in the United States District Court for the Eastern District of Virginia, requesting a declaration that UCB’s Cim-zia® brand antibody does not infringe Yeda’s U.S. Patent No. 6,090,923 (“the ’923 Patent”); UCB also sought a declaration that the ’923 Patent is invalid. Yeda counterclaimed for. infringement. The district court granted summary judgment of non-infringement, holding that, based on the specification and prosecution history, the monoclonal antibodies claimed in the ’923 patent…
2Cases cited5 opinions
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- Teva Pharm. United States, Inc. v. Sandoz, Inc.Supreme Court of the United States · 2015
- Builders Concrete, Inc. v. Bremerton Concrete Products CompanyCourt of Appeals for the Federal Circuit · 1985
- Advance Transformer Co. v. Melvin L. LevinsonCourt of Appeals for the Federal Circuit · 1988
- UCB, Inc. v. Yeda Research & Development Co.District Court, E.D. Virginia · 2015
3Cited by7 opinions
- United States v. HaneyCourt of Appeals for the Seventh Circuit · 2016
- Abiomed, Inc. v. Maquet Cardiovascular LLCDistrict Court, District of Columbia · 2018
- Agilent Technologies, Inc. v. Axion Biosystems, Inc.District Court, D. Delaware · 2025
- BE Labs, Inc. v. Ubiquiti Inc.District Court, S.D. New York · 2026
- Davis Innovations, Inc. v. SIG Sauer, Inc., et al.District Court, D. New Hampshire · 2017
2 more not listed; retrieve them via the Exa API.